THE OUTSOURCING FACILITIES ASSOCIATION (OFA) WELCOMES YOU

Working Together For The 503B Industry

Welcome to the Outsourcing Facility Association. Our main goal is to provide support, resources and engagement on behalf of the 503B industry and our members. Browse through our site to discover what we’re all about.

COVID-19 Drug Shortage Product List

FDA Drug Shortage Product List

Contact Outsourcing Facilities

NOTICE TO HOSPITALS

Cannot obtain FDA-approved drugs?
Outsourcing Facilities are subject to MORE QUALITY STANDARDS than other compounders and supply drugs in shortage.

Hospitals that cannot obtain adequate supplies of FDA-approved drugs and are considering the use of compounded drugs for their hospitalized patients should first contact outsourcing facilities, which are subject to more robust quality standards than state-licensed pharmacies or federal facilities that do not register with FDA as outsourcing facilities.

If you are a Hospital that cannot find a COVID-19 drug in shortage, let us know!

OFA%25252520Logo_edited_edited_edited_edited.png

ABOUT THE OFA

The Outsourcing Facilities Association (OFA) is the trade association representing FDA-registered 503B outsourcing facilities who focus on providing patients and healthcare providers with safe and effective compounded medications. OFA members work with patients, healthcare providers, and facilities on a daily basis to ensure the specific needs, of both providers and patients, for compounded medications are satisfied. OFA will continue to work with industry, governmental agencies, and healthcare providers to educate and advocate for outsourcing facilities and the critical need to ensure that patients and providers have access to the medications they need.

Get in Touch

503B POSSIBLE SOURCES OF DRUGS USED FOR HOSPITALIZED PATIENTS WITH COVID-19

(updated daily, last update July 15)

Not every 503B listed below is a member of OFA. If you would like to speak with any of the 503Bs listed below, please reach out directly to the 503B. The information below is directly from the publicly available FDA website and required 6-month product reports published by the FDA. In addition, 503Bs who are developing formulations, which may be released soon, may also have a product listed. If you are associated with the 503B and want to update this information, please reach out to OFA at any time to update this information.

The products listed below are related to FDA's List of Drugs Used for Hospitalized Patients with COVID-19 in FDA's Temporary Policy for Compounding of Certain Drugs for Hospitalized Patients by Outsourcing Facilities During the COVID-19 Public Health Emergency. OFA makes NO representation to the quantity or nature of any product listed below. Please reach out to the company directly for additional information. OFA has no pricing data for any product listed below and all questions should be directed to the 503B directly.

Many of these 503Bs have additional products available that are listed on FDA's Drug Shortage List. Please inquire with 503Bs directly for a full product catalog.

List is updated daily - 503Bs click here to submit updates

FDA's List of Drugs Used for Hospitalized Patients

with COVID-19

FDA Drug Shortage

APOLLO CARE

Fentanyl citrate

Norepinephrine bitartrate

Vancomycin hydrochloride